Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Scientific Officer
-
Issuer Symbol
-
RYTM on Nasdaq
Alastair Garfield - trading volume in the past year for RHYTHM PHARMACEUTICALS, INC.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Restricted Stock Units |
13,333 |
$1,524,913 |
$57.22 |
01 Jul 2025 |
Direct |
Common Stock |
|
| Common Stock |
3,126 |
$201,939 |
$64.60 |
02 Jul 2025 |
Direct |
|
|
| Stock Option (right to buy) |
53,333 |
|
|
08 Jul 2024 |
Direct |
Common Stock |
|
| Stock Options (Right to Buy) |
40,000 |
|
|
14 Feb 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.